nodes	percent_of_prediction	percent_of_DWPC	metapath
Icatibant—ANPEP—Ezetimibe—atherosclerosis	0.825	1	CbGbCtD
Icatibant—BDKRB2—penis—atherosclerosis	0.0303	0.663	CbGeAlD
Icatibant—ANPEP—Metabolism of Angiotensinogen to Angiotensins—ACE—atherosclerosis	0.00443	0.04	CbGpPWpGaD
Icatibant—BDKRB2—adipose tissue—atherosclerosis	0.00429	0.0941	CbGeAlD
Icatibant—BDKRB2—ACE Inhibitor Pathway—ACE—atherosclerosis	0.00386	0.0349	CbGpPWpGaD
Icatibant—BDKRB2—ACE Inhibitor Pathway—KNG1—atherosclerosis	0.0035	0.0316	CbGpPWpGaD
Icatibant—ANPEP—connective tissue—atherosclerosis	0.00349	0.0765	CbGeAlD
Icatibant—BDKRB2—ACE Inhibitor Pathway—AGTR1—atherosclerosis	0.00348	0.0314	CbGpPWpGaD
Icatibant—ANPEP—cardiovascular system—atherosclerosis	0.00304	0.0665	CbGeAlD
Icatibant—ANPEP—Metabolism of Angiotensinogen to Angiotensins—AGT—atherosclerosis	0.00281	0.0254	CbGpPWpGaD
Icatibant—ANPEP—adipose tissue—atherosclerosis	0.00268	0.0587	CbGeAlD
Icatibant—ANPEP—Glutathione metabolism—GSTM1—atherosclerosis	0.0025	0.0226	CbGpPWpGaD
Icatibant—BDKRB2—ACE Inhibitor Pathway—AGT—atherosclerosis	0.00245	0.0221	CbGpPWpGaD
Icatibant—ANPEP—Glutathione metabolism—GPX1—atherosclerosis	0.0024	0.0216	CbGpPWpGaD
Icatibant—ANPEP—C-MYB transcription factor network—CSF1R—atherosclerosis	0.00212	0.0191	CbGpPWpGaD
Icatibant—ANPEP—Peptide hormone metabolism—PLA2G7—atherosclerosis	0.00206	0.0186	CbGpPWpGaD
Icatibant—ANPEP—liver—atherosclerosis	0.00188	0.0411	CbGeAlD
Icatibant—BDKRB2—ACE Inhibitor Pathway—NOS3—atherosclerosis	0.0018	0.0162	CbGpPWpGaD
Icatibant—BDKRB2—Peptide GPCRs—CX3CR1—atherosclerosis	0.00175	0.0158	CbGpPWpGaD
Icatibant—ANPEP—C-MYB transcription factor network—MPO—atherosclerosis	0.00142	0.0128	CbGpPWpGaD
Icatibant—ANPEP—Cardiac Progenitor Differentiation—IGF2—atherosclerosis	0.00136	0.0123	CbGpPWpGaD
Icatibant—BDKRB2—G alpha (q) signalling events—HRH1—atherosclerosis	0.00135	0.0121	CbGpPWpGaD
Icatibant—BDKRB2—Peptide GPCRs—EDNRA—atherosclerosis	0.00126	0.0114	CbGpPWpGaD
Icatibant—BDKRB2—Peptide GPCRs—CCR2—atherosclerosis	0.00126	0.0114	CbGpPWpGaD
Icatibant—BDKRB2—Gastrin-CREB signalling pathway via PKC and MAPK—HRH1—atherosclerosis	0.0012	0.0109	CbGpPWpGaD
Icatibant—ANPEP—Peptide hormone metabolism—GHRL—atherosclerosis	0.0012	0.0109	CbGpPWpGaD
Icatibant—BDKRB2—ACE Inhibitor Pathway—TGFB1—atherosclerosis	0.00119	0.0107	CbGpPWpGaD
Icatibant—ANPEP—Peptide hormone metabolism—ACE—atherosclerosis	0.00117	0.0105	CbGpPWpGaD
Icatibant—BDKRB2—Peptide GPCRs—AGTR1—atherosclerosis	0.00107	0.00968	CbGpPWpGaD
Icatibant—BDKRB2—GPCRs, Class A Rhodopsin-like—HRH1—atherosclerosis	0.00104	0.00939	CbGpPWpGaD
Icatibant—BDKRB2—Direct p53 effectors—CX3CL1—atherosclerosis	0.00103	0.00927	CbGpPWpGaD
Icatibant—BDKRB2—Peptide ligand-binding receptors—CCL4—atherosclerosis	0.000961	0.00867	CbGpPWpGaD
Icatibant—ANPEP—Cardiac Progenitor Differentiation—INS—atherosclerosis	0.000903	0.00814	CbGpPWpGaD
Icatibant—BDKRB2—Class A/1 (Rhodopsin-like receptors)—HRH1—atherosclerosis	0.000892	0.00804	CbGpPWpGaD
Icatibant—ANPEP—C-MYB transcription factor network—GSTM1—atherosclerosis	0.000889	0.00802	CbGpPWpGaD
Icatibant—ANPEP—Cardiac Progenitor Differentiation—IGF1—atherosclerosis	0.000873	0.00788	CbGpPWpGaD
Icatibant—BDKRB2—G alpha (q) signalling events—UTS2—atherosclerosis	0.000867	0.00783	CbGpPWpGaD
Icatibant—BDKRB2—Peptide ligand-binding receptors—UTS2—atherosclerosis	0.000856	0.00773	CbGpPWpGaD
Icatibant—BDKRB2—G alpha (q) signalling events—CASR—atherosclerosis	0.000832	0.0075	CbGpPWpGaD
Icatibant—BDKRB2—Direct p53 effectors—HSPA1B—atherosclerosis	0.000829	0.00748	CbGpPWpGaD
Icatibant—BDKRB2—Peptide ligand-binding receptors—CX3CR1—atherosclerosis	0.000821	0.00741	CbGpPWpGaD
Icatibant—BDKRB2—Peptide ligand-binding receptors—CX3CL1—atherosclerosis	0.000805	0.00726	CbGpPWpGaD
Icatibant—BDKRB2—Gastrin-CREB signalling pathway via PKC and MAPK—UTS2—atherosclerosis	0.000776	0.007	CbGpPWpGaD
Icatibant—BDKRB2—Gastrin-CREB signalling pathway via PKC and MAPK—CASR—atherosclerosis	0.000744	0.00671	CbGpPWpGaD
Icatibant—ANPEP—Peptide hormone metabolism—AGT—atherosclerosis	0.000739	0.00667	CbGpPWpGaD
Icatibant—ANPEP—Peptide hormone metabolism—LEP—atherosclerosis	0.000724	0.00653	CbGpPWpGaD
Icatibant—BDKRB2—G alpha (i) signalling events—CASR—atherosclerosis	0.000693	0.00625	CbGpPWpGaD
Icatibant—BDKRB2—GPCR ligand binding—HRH1—atherosclerosis	0.000679	0.00612	CbGpPWpGaD
Icatibant—BDKRB2—Peptide ligand-binding receptors—CCL3—atherosclerosis	0.000656	0.00592	CbGpPWpGaD
Icatibant—BDKRB2—Class A/1 (Rhodopsin-like receptors)—CCL4—atherosclerosis	0.000645	0.00581	CbGpPWpGaD
Icatibant—BDKRB2—G alpha (i) signalling events—CNR2—atherosclerosis	0.000644	0.00581	CbGpPWpGaD
Icatibant—BDKRB2—GPCRs, Class A Rhodopsin-like—CX3CR1—atherosclerosis	0.000643	0.0058	CbGpPWpGaD
Icatibant—Nervous system disorder—Rosuvastatin—atherosclerosis	0.000639	0.0352	CcSEcCtD
Icatibant—ANPEP—Peptide hormone metabolism—INS—atherosclerosis	0.000619	0.00558	CbGpPWpGaD
Icatibant—BDKRB2—Regulation of Actin Cytoskeleton—CD14—atherosclerosis	0.000604	0.00545	CbGpPWpGaD
Icatibant—BDKRB2—G alpha (q) signalling events—EDNRA—atherosclerosis	0.000601	0.00542	CbGpPWpGaD
Icatibant—ANPEP—Peptide hormone metabolism—IGF1—atherosclerosis	0.000598	0.0054	CbGpPWpGaD
Icatibant—BDKRB2—GPCRs, Class A Rhodopsin-like—CNR2—atherosclerosis	0.000598	0.00539	CbGpPWpGaD
Icatibant—BDKRB2—Peptide ligand-binding receptors—EDNRA—atherosclerosis	0.000594	0.00536	CbGpPWpGaD
Icatibant—BDKRB2—Peptide ligand-binding receptors—CCR2—atherosclerosis	0.000594	0.00536	CbGpPWpGaD
Icatibant—BDKRB2—G alpha (q) signalling events—GHRL—atherosclerosis	0.000586	0.00529	CbGpPWpGaD
Icatibant—BDKRB2—Peptide ligand-binding receptors—GHRL—atherosclerosis	0.000579	0.00522	CbGpPWpGaD
Icatibant—BDKRB2—Class A/1 (Rhodopsin-like receptors)—UTS2—atherosclerosis	0.000574	0.00518	CbGpPWpGaD
Icatibant—Anaphylactic shock—Lovastatin—atherosclerosis	0.000552	0.0304	CcSEcCtD
Icatibant—BDKRB2—Class A/1 (Rhodopsin-like receptors)—CX3CR1—atherosclerosis	0.000551	0.00497	CbGpPWpGaD
Icatibant—Anaphylactic shock—Ezetimibe—atherosclerosis	0.000542	0.0298	CcSEcCtD
Icatibant—BDKRB2—Class A/1 (Rhodopsin-like receptors)—CX3CL1—atherosclerosis	0.00054	0.00487	CbGpPWpGaD
Icatibant—BDKRB2—Gastrin-CREB signalling pathway via PKC and MAPK—EDNRA—atherosclerosis	0.000538	0.00485	CbGpPWpGaD
Icatibant—Nervous system disorder—Ezetimibe—atherosclerosis	0.000531	0.0292	CcSEcCtD
Icatibant—BDKRB2—Gastrin-CREB signalling pathway via PKC and MAPK—GHRL—atherosclerosis	0.000524	0.00473	CbGpPWpGaD
Icatibant—ANPEP—Cardiac Progenitor Differentiation—TGFB1—atherosclerosis	0.000523	0.00472	CbGpPWpGaD
Icatibant—BDKRB2—Direct p53 effectors—GPX1—atherosclerosis	0.000517	0.00467	CbGpPWpGaD
Icatibant—Anaphylactic shock—Simvastatin—atherosclerosis	0.000517	0.0284	CcSEcCtD
Icatibant—BDKRB2—G alpha (q) signalling events—KNG1—atherosclerosis	0.000514	0.00464	CbGpPWpGaD
Icatibant—BDKRB2—Class A/1 (Rhodopsin-like receptors)—CNR2—atherosclerosis	0.000512	0.00462	CbGpPWpGaD
Icatibant—BDKRB2—G alpha (q) signalling events—AGTR1—atherosclerosis	0.000511	0.00461	CbGpPWpGaD
Icatibant—BDKRB2—Peptide ligand-binding receptors—KNG1—atherosclerosis	0.000508	0.00458	CbGpPWpGaD
Icatibant—BDKRB2—Peptide ligand-binding receptors—AGTR1—atherosclerosis	0.000505	0.00455	CbGpPWpGaD
Icatibant—BDKRB2—Direct p53 effectors—SPP1—atherosclerosis	0.000502	0.00453	CbGpPWpGaD
Icatibant—ANPEP—C-MYB transcription factor network—PTGS2—atherosclerosis	0.000501	0.00452	CbGpPWpGaD
Icatibant—BDKRB2—G alpha (i) signalling events—CCR2—atherosclerosis	0.000501	0.00452	CbGpPWpGaD
Icatibant—BDKRB2—GPCR ligand binding—CCL4—atherosclerosis	0.000491	0.00443	CbGpPWpGaD
Icatibant—Hypersensitivity—Rosuvastatin—atherosclerosis	0.00048	0.0264	CcSEcCtD
Icatibant—Anaphylactic shock—Niacin—atherosclerosis	0.000474	0.0261	CcSEcCtD
Icatibant—Anaphylactic shock—Pravastatin—atherosclerosis	0.000467	0.0257	CcSEcCtD
Icatibant—BDKRB2—GPCRs, Class A Rhodopsin-like—CCR2—atherosclerosis	0.000465	0.00419	CbGpPWpGaD
Icatibant—BDKRB2—GPCRs, Class A Rhodopsin-like—EDNRA—atherosclerosis	0.000465	0.00419	CbGpPWpGaD
Icatibant—BDKRB2—Gastrin-CREB signalling pathway via PKC and MAPK—KNG1—atherosclerosis	0.00046	0.00415	CbGpPWpGaD
Icatibant—BDKRB2—Gastrin-CREB signalling pathway via PKC and MAPK—AGTR1—atherosclerosis	0.000457	0.00413	CbGpPWpGaD
Icatibant—BDKRB2—Regulation of Actin Cytoskeleton—PDGFB—atherosclerosis	0.000442	0.00399	CbGpPWpGaD
Icatibant—BDKRB2—Class A/1 (Rhodopsin-like receptors)—CCL3—atherosclerosis	0.00044	0.00397	CbGpPWpGaD
Icatibant—BDKRB2—Direct p53 effectors—CAV1—atherosclerosis	0.00044	0.00397	CbGpPWpGaD
Icatibant—BDKRB2—GPCR ligand binding—UTS2—atherosclerosis	0.000437	0.00395	CbGpPWpGaD
Icatibant—Body temperature increased—Lovastatin—atherosclerosis	0.000437	0.024	CcSEcCtD
Icatibant—BDKRB2—G alpha (q) signalling events—EDN1—atherosclerosis	0.000433	0.00391	CbGpPWpGaD
Icatibant—Dizziness—Rosuvastatin—atherosclerosis	0.000431	0.0237	CcSEcCtD
Icatibant—BDKRB2—G alpha (i) signalling events—KNG1—atherosclerosis	0.000428	0.00386	CbGpPWpGaD
Icatibant—Body temperature increased—Ezetimibe—atherosclerosis	0.000428	0.0236	CcSEcCtD
Icatibant—BDKRB2—Peptide ligand-binding receptors—EDN1—atherosclerosis	0.000428	0.00386	CbGpPWpGaD
Icatibant—BDKRB2—Peptide ligand-binding receptors—CCL5—atherosclerosis	0.000425	0.00383	CbGpPWpGaD
Icatibant—BDKRB2—GPCR ligand binding—CX3CR1—atherosclerosis	0.000419	0.00378	CbGpPWpGaD
Icatibant—BDKRB2—GPCR ligand binding—CASR—atherosclerosis	0.000419	0.00378	CbGpPWpGaD
Icatibant—BDKRB2—GPCR ligand binding—CX3CL1—atherosclerosis	0.000411	0.00371	CbGpPWpGaD
Icatibant—Rash—Rosuvastatin—atherosclerosis	0.000411	0.0226	CcSEcCtD
Icatibant—Dermatitis—Rosuvastatin—atherosclerosis	0.00041	0.0226	CcSEcCtD
Icatibant—Body temperature increased—Simvastatin—atherosclerosis	0.000408	0.0225	CcSEcCtD
Icatibant—Headache—Rosuvastatin—atherosclerosis	0.000408	0.0225	CcSEcCtD
Icatibant—BDKRB2—Gastrin-CREB signalling pathway via PKC and MAPK—MMP3—atherosclerosis	0.000408	0.00368	CbGpPWpGaD
Icatibant—Hypersensitivity—Lovastatin—atherosclerosis	0.000407	0.0224	CcSEcCtD
Icatibant—Hypersensitivity—Ezetimibe—atherosclerosis	0.000399	0.022	CcSEcCtD
Icatibant—BDKRB2—Regulation of Actin Cytoskeleton—F2—atherosclerosis	0.000399	0.0036	CbGpPWpGaD
Icatibant—BDKRB2—Class A/1 (Rhodopsin-like receptors)—EDNRA—atherosclerosis	0.000398	0.00359	CbGpPWpGaD
Icatibant—BDKRB2—Class A/1 (Rhodopsin-like receptors)—CCR2—atherosclerosis	0.000398	0.00359	CbGpPWpGaD
Icatibant—BDKRB2—GPCRs, Class A Rhodopsin-like—AGTR1—atherosclerosis	0.000395	0.00357	CbGpPWpGaD
Icatibant—BDKRB2—GPCR ligand binding—CNR2—atherosclerosis	0.00039	0.00352	CbGpPWpGaD
Icatibant—ANPEP—Metabolism of proteins—PLA2G7—atherosclerosis	0.000389	0.00351	CbGpPWpGaD
Icatibant—BDKRB2—Class A/1 (Rhodopsin-like receptors)—GHRL—atherosclerosis	0.000388	0.0035	CbGpPWpGaD
Icatibant—BDKRB2—Gastrin-CREB signalling pathway via PKC and MAPK—EDN1—atherosclerosis	0.000388	0.0035	CbGpPWpGaD
Icatibant—Nausea—Rosuvastatin—atherosclerosis	0.000387	0.0213	CcSEcCtD
Icatibant—BDKRB2—GPCR downstream signaling—HRH1—atherosclerosis	0.000384	0.00346	CbGpPWpGaD
Icatibant—BDKRB2—Regulation of Actin Cytoskeleton—PIK3CG—atherosclerosis	0.000382	0.00344	CbGpPWpGaD
Icatibant—Hypersensitivity—Simvastatin—atherosclerosis	0.000381	0.0209	CcSEcCtD
Icatibant—Body temperature increased—Niacin—atherosclerosis	0.000375	0.0206	CcSEcCtD
Icatibant—Body temperature increased—Pravastatin—atherosclerosis	0.000369	0.0203	CcSEcCtD
Icatibant—Dizziness—Lovastatin—atherosclerosis	0.000365	0.0201	CcSEcCtD
Icatibant—BDKRB2—G alpha (q) signalling events—AGT—atherosclerosis	0.00036	0.00325	CbGpPWpGaD
Icatibant—BDKRB2—G alpha (i) signalling events—CCL5—atherosclerosis	0.000358	0.00323	CbGpPWpGaD
Icatibant—Dizziness—Ezetimibe—atherosclerosis	0.000358	0.0197	CcSEcCtD
Icatibant—BDKRB2—Direct p53 effectors—MMP2—atherosclerosis	0.000355	0.00321	CbGpPWpGaD
Icatibant—BDKRB2—Peptide ligand-binding receptors—AGT—atherosclerosis	0.000355	0.0032	CbGpPWpGaD
Icatibant—Hypersensitivity—Niacin—atherosclerosis	0.000349	0.0192	CcSEcCtD
Icatibant—BDKRB2—Direct p53 effectors—SERPINE1—atherosclerosis	0.000349	0.00315	CbGpPWpGaD
Icatibant—BDKRB2—Signaling by GPCR—HRH1—atherosclerosis	0.000348	0.00314	CbGpPWpGaD
Icatibant—Rash—Lovastatin—atherosclerosis	0.000348	0.0192	CcSEcCtD
Icatibant—Dermatitis—Lovastatin—atherosclerosis	0.000348	0.0191	CcSEcCtD
Icatibant—Headache—Lovastatin—atherosclerosis	0.000346	0.019	CcSEcCtD
Icatibant—Hypersensitivity—Pravastatin—atherosclerosis	0.000344	0.0189	CcSEcCtD
Icatibant—Dizziness—Simvastatin—atherosclerosis	0.000342	0.0188	CcSEcCtD
Icatibant—Rash—Ezetimibe—atherosclerosis	0.000341	0.0188	CcSEcCtD
Icatibant—Dermatitis—Ezetimibe—atherosclerosis	0.000341	0.0188	CcSEcCtD
Icatibant—BDKRB2—Class A/1 (Rhodopsin-like receptors)—KNG1—atherosclerosis	0.000341	0.00307	CbGpPWpGaD
Icatibant—Headache—Ezetimibe—atherosclerosis	0.000339	0.0187	CcSEcCtD
Icatibant—BDKRB2—Class A/1 (Rhodopsin-like receptors)—AGTR1—atherosclerosis	0.000339	0.00305	CbGpPWpGaD
Icatibant—BDKRB2—GPCR ligand binding—CCL3—atherosclerosis	0.000335	0.00302	CbGpPWpGaD
Icatibant—BDKRB2—G alpha (q) signalling events—F2—atherosclerosis	0.000332	0.003	CbGpPWpGaD
Icatibant—BDKRB2—Peptide ligand-binding receptors—F2—atherosclerosis	0.000328	0.00296	CbGpPWpGaD
Icatibant—Nausea—Lovastatin—atherosclerosis	0.000328	0.0181	CcSEcCtD
Icatibant—Rash—Simvastatin—atherosclerosis	0.000326	0.0179	CcSEcCtD
Icatibant—Dermatitis—Simvastatin—atherosclerosis	0.000325	0.0179	CcSEcCtD
Icatibant—Headache—Simvastatin—atherosclerosis	0.000324	0.0178	CcSEcCtD
Icatibant—BDKRB2—Gastrin-CREB signalling pathway via PKC and MAPK—AGT—atherosclerosis	0.000322	0.0029	CbGpPWpGaD
Icatibant—Nausea—Ezetimibe—atherosclerosis	0.000322	0.0177	CcSEcCtD
Icatibant—ANPEP—Metabolism of proteins—HSPD1—atherosclerosis	0.000316	0.00285	CbGpPWpGaD
Icatibant—Dizziness—Niacin—atherosclerosis	0.000314	0.0173	CcSEcCtD
Icatibant—Dizziness—Pravastatin—atherosclerosis	0.000309	0.017	CcSEcCtD
Icatibant—Nausea—Simvastatin—atherosclerosis	0.000307	0.0169	CcSEcCtD
Icatibant—BDKRB2—GPCR ligand binding—EDNRA—atherosclerosis	0.000303	0.00274	CbGpPWpGaD
Icatibant—BDKRB2—GPCR ligand binding—CCR2—atherosclerosis	0.000303	0.00274	CbGpPWpGaD
Icatibant—BDKRB2—G alpha (i) signalling events—AGT—atherosclerosis	0.0003	0.0027	CbGpPWpGaD
Icatibant—Rash—Niacin—atherosclerosis	0.000299	0.0165	CcSEcCtD
Icatibant—Dermatitis—Niacin—atherosclerosis	0.000299	0.0164	CcSEcCtD
Icatibant—BDKRB2—Gastrin-CREB signalling pathway via PKC and MAPK—F2—atherosclerosis	0.000297	0.00268	CbGpPWpGaD
Icatibant—Headache—Niacin—atherosclerosis	0.000297	0.0164	CcSEcCtD
Icatibant—BDKRB2—GPCR ligand binding—GHRL—atherosclerosis	0.000296	0.00267	CbGpPWpGaD
Icatibant—Rash—Pravastatin—atherosclerosis	0.000294	0.0162	CcSEcCtD
Icatibant—Dermatitis—Pravastatin—atherosclerosis	0.000294	0.0162	CcSEcCtD
Icatibant—BDKRB2—Peptide ligand-binding receptors—CCL2—atherosclerosis	0.000293	0.00264	CbGpPWpGaD
Icatibant—Headache—Pravastatin—atherosclerosis	0.000293	0.0161	CcSEcCtD
Icatibant—BDKRB2—Class A/1 (Rhodopsin-like receptors)—EDN1—atherosclerosis	0.000287	0.00259	CbGpPWpGaD
Icatibant—BDKRB2—Class A/1 (Rhodopsin-like receptors)—CCL5—atherosclerosis	0.000285	0.00257	CbGpPWpGaD
Icatibant—Nausea—Niacin—atherosclerosis	0.000282	0.0155	CcSEcCtD
Icatibant—Nausea—Pravastatin—atherosclerosis	0.000277	0.0153	CcSEcCtD
Icatibant—BDKRB2—GPCR ligand binding—KNG1—atherosclerosis	0.000259	0.00234	CbGpPWpGaD
Icatibant—BDKRB2—GPCR ligand binding—AGTR1—atherosclerosis	0.000258	0.00233	CbGpPWpGaD
Icatibant—ANPEP—Metabolism of proteins—F7—atherosclerosis	0.000255	0.0023	CbGpPWpGaD
Icatibant—BDKRB2—Signaling by GPCR—CCL4—atherosclerosis	0.000252	0.00227	CbGpPWpGaD
Icatibant—BDKRB2—GPCR downstream signaling—UTS2—atherosclerosis	0.000247	0.00223	CbGpPWpGaD
Icatibant—BDKRB2—Class A/1 (Rhodopsin-like receptors)—AGT—atherosclerosis	0.000238	0.00215	CbGpPWpGaD
Icatibant—BDKRB2—GPCR downstream signaling—CASR—atherosclerosis	0.000237	0.00214	CbGpPWpGaD
Icatibant—BDKRB2—Peptide ligand-binding receptors—CXCL8—atherosclerosis	0.000231	0.00209	CbGpPWpGaD
Icatibant—ANPEP—Metabolism of proteins—GHRL—atherosclerosis	0.000227	0.00205	CbGpPWpGaD
Icatibant—BDKRB2—Signaling by GPCR—UTS2—atherosclerosis	0.000225	0.00203	CbGpPWpGaD
Icatibant—BDKRB2—GPCR downstream signaling—CNR2—atherosclerosis	0.00022	0.00199	CbGpPWpGaD
Icatibant—BDKRB2—Class A/1 (Rhodopsin-like receptors)—F2—atherosclerosis	0.00022	0.00199	CbGpPWpGaD
Icatibant—ANPEP—Metabolism of proteins—ACE—atherosclerosis	0.00022	0.00199	CbGpPWpGaD
Icatibant—BDKRB2—GPCR ligand binding—EDN1—atherosclerosis	0.000219	0.00197	CbGpPWpGaD
Icatibant—BDKRB2—GPCR ligand binding—CCL5—atherosclerosis	0.000217	0.00196	CbGpPWpGaD
Icatibant—BDKRB2—Regulation of Actin Cytoskeleton—MAPK3—atherosclerosis	0.000216	0.00195	CbGpPWpGaD
Icatibant—BDKRB2—Signaling by GPCR—CX3CR1—atherosclerosis	0.000215	0.00194	CbGpPWpGaD
Icatibant—BDKRB2—Signaling by GPCR—CASR—atherosclerosis	0.000215	0.00194	CbGpPWpGaD
Icatibant—BDKRB2—Signaling by GPCR—CX3CL1—atherosclerosis	0.000211	0.0019	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—HRH1—atherosclerosis	0.000206	0.00186	CbGpPWpGaD
Icatibant—BDKRB2—Signaling by GPCR—CNR2—atherosclerosis	0.0002	0.00181	CbGpPWpGaD
Icatibant—ANPEP—Metabolism of proteins—PLAUR—atherosclerosis	0.000198	0.00178	CbGpPWpGaD
Icatibant—BDKRB2—Class A/1 (Rhodopsin-like receptors)—CCL2—atherosclerosis	0.000196	0.00177	CbGpPWpGaD
Icatibant—BDKRB2—G alpha (i) signalling events—CXCL8—atherosclerosis	0.000195	0.00176	CbGpPWpGaD
Icatibant—ANPEP—Metabolism of proteins—PLG—atherosclerosis	0.000193	0.00174	CbGpPWpGaD
Icatibant—BDKRB2—GPCR ligand binding—AGT—atherosclerosis	0.000181	0.00164	CbGpPWpGaD
Icatibant—ANPEP—Metabolism of proteins—IGF2—atherosclerosis	0.000176	0.00159	CbGpPWpGaD
Icatibant—BDKRB2—Signaling by GPCR—CCL3—atherosclerosis	0.000172	0.00155	CbGpPWpGaD
Icatibant—BDKRB2—GPCR downstream signaling—EDNRA—atherosclerosis	0.000171	0.00155	CbGpPWpGaD
Icatibant—BDKRB2—GPCR downstream signaling—CCR2—atherosclerosis	0.000171	0.00155	CbGpPWpGaD
Icatibant—BDKRB2—GPCR ligand binding—F2—atherosclerosis	0.000168	0.00151	CbGpPWpGaD
Icatibant—BDKRB2—GPCR downstream signaling—GHRL—atherosclerosis	0.000167	0.00151	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—APOA4—atherosclerosis	0.000162	0.00146	CbGpPWpGaD
Icatibant—BDKRB2—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK3—atherosclerosis	0.000161	0.00145	CbGpPWpGaD
Icatibant—BDKRB2—Signaling by GPCR—EDNRA—atherosclerosis	0.000156	0.0014	CbGpPWpGaD
Icatibant—BDKRB2—Signaling by GPCR—CCR2—atherosclerosis	0.000156	0.0014	CbGpPWpGaD
Icatibant—BDKRB2—Class A/1 (Rhodopsin-like receptors)—CXCL8—atherosclerosis	0.000155	0.0014	CbGpPWpGaD
Icatibant—BDKRB2—Signaling by GPCR—GHRL—atherosclerosis	0.000152	0.00137	CbGpPWpGaD
Icatibant—BDKRB2—GPCR ligand binding—CCL2—atherosclerosis	0.000149	0.00135	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—CCL4—atherosclerosis	0.000149	0.00134	CbGpPWpGaD
Icatibant—BDKRB2—GPCR downstream signaling—KNG1—atherosclerosis	0.000147	0.00132	CbGpPWpGaD
Icatibant—BDKRB2—GPCR downstream signaling—AGTR1—atherosclerosis	0.000146	0.00131	CbGpPWpGaD
Icatibant—ANPEP—Metabolism of proteins—MMP1—atherosclerosis	0.000141	0.00127	CbGpPWpGaD
Icatibant—ANPEP—Metabolism of proteins—AGT—atherosclerosis	0.00014	0.00126	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—APOA2—atherosclerosis	0.000139	0.00125	CbGpPWpGaD
Icatibant—ANPEP—Metabolism of proteins—LEP—atherosclerosis	0.000137	0.00123	CbGpPWpGaD
Icatibant—BDKRB2—Signaling by GPCR—KNG1—atherosclerosis	0.000133	0.0012	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—UTS2—atherosclerosis	0.000133	0.0012	CbGpPWpGaD
Icatibant—BDKRB2—Signaling by GPCR—AGTR1—atherosclerosis	0.000132	0.00119	CbGpPWpGaD
Icatibant—ANPEP—Metabolism of proteins—F2—atherosclerosis	0.000129	0.00116	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—CX3CR1—atherosclerosis	0.000127	0.00115	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—CASR—atherosclerosis	0.000127	0.00115	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—CX3CL1—atherosclerosis	0.000125	0.00112	CbGpPWpGaD
Icatibant—BDKRB2—GPCR downstream signaling—EDN1—atherosclerosis	0.000124	0.00111	CbGpPWpGaD
Icatibant—BDKRB2—GPCR downstream signaling—CCL5—atherosclerosis	0.000123	0.00111	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—CNR2—atherosclerosis	0.000118	0.00107	CbGpPWpGaD
Icatibant—BDKRB2—GPCR ligand binding—CXCL8—atherosclerosis	0.000118	0.00107	CbGpPWpGaD
Icatibant—BDKRB2—Signaling by GPCR—MMP3—atherosclerosis	0.000118	0.00106	CbGpPWpGaD
Icatibant—BDKRB2—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—atherosclerosis	0.000118	0.00106	CbGpPWpGaD
Icatibant—ANPEP—Metabolism of proteins—INS—atherosclerosis	0.000117	0.00105	CbGpPWpGaD
Icatibant—BDKRB2—GPCR downstream signaling—PRKCG—atherosclerosis	0.000117	0.00105	CbGpPWpGaD
Icatibant—ANPEP—Metabolism of proteins—CCL2—atherosclerosis	0.000115	0.00104	CbGpPWpGaD
Icatibant—ANPEP—Metabolism of proteins—IGF1—atherosclerosis	0.000113	0.00102	CbGpPWpGaD
Icatibant—BDKRB2—Signaling by GPCR—EDN1—atherosclerosis	0.000112	0.00101	CbGpPWpGaD
Icatibant—BDKRB2—Signaling by GPCR—CCL5—atherosclerosis	0.000111	0.001	CbGpPWpGaD
Icatibant—ANPEP—Metabolism of proteins—MMP2—atherosclerosis	0.000109	0.000986	CbGpPWpGaD
Icatibant—BDKRB2—Signaling by GPCR—PRKCG—atherosclerosis	0.000106	0.000955	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—VWF—atherosclerosis	0.000105	0.00095	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—APOC3—atherosclerosis	0.000105	0.000945	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—LDLR—atherosclerosis	0.000104	0.000939	CbGpPWpGaD
Icatibant—BDKRB2—GPCR downstream signaling—AGT—atherosclerosis	0.000103	0.000925	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—CCL3—atherosclerosis	0.000102	0.000917	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—NCF1—atherosclerosis	9.73e-05	0.000878	CbGpPWpGaD
Icatibant—BDKRB2—GPCR downstream signaling—F2—atherosclerosis	9.47e-05	0.000855	CbGpPWpGaD
Icatibant—BDKRB2—Signaling by GPCR—AGT—atherosclerosis	9.31e-05	0.00084	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—EDNRA—atherosclerosis	9.19e-05	0.000829	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—CCR2—atherosclerosis	9.19e-05	0.000829	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—CYBA—atherosclerosis	9.15e-05	0.000826	CbGpPWpGaD
Icatibant—ANPEP—Metabolism of proteins—CXCL8—atherosclerosis	9.09e-05	0.00082	CbGpPWpGaD
Icatibant—BDKRB2—GPCR downstream signaling—PIK3CG—atherosclerosis	9.07e-05	0.000818	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—PARP1—atherosclerosis	8.96e-05	0.000808	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—PLAT—atherosclerosis	8.96e-05	0.000808	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—GHRL—atherosclerosis	8.96e-05	0.000808	CbGpPWpGaD
Icatibant—BDKRB2—Signaling by GPCR—F2—atherosclerosis	8.6e-05	0.000776	CbGpPWpGaD
Icatibant—BDKRB2—Signaling by GPCR—PIK3CG—atherosclerosis	8.23e-05	0.000743	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—KNG1—atherosclerosis	7.86e-05	0.000709	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—AGTR1—atherosclerosis	7.82e-05	0.000705	CbGpPWpGaD
Icatibant—BDKRB2—Signaling by GPCR—CCL2—atherosclerosis	7.67e-05	0.000692	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—PLG—atherosclerosis	7.62e-05	0.000687	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—SOCS3—atherosclerosis	7.21e-05	0.000651	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—MMP3—atherosclerosis	6.97e-05	0.000629	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—IGF2—atherosclerosis	6.94e-05	0.000626	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—APOB—atherosclerosis	6.73e-05	0.000607	CbGpPWpGaD
Icatibant—BDKRB2—GPCR downstream signaling—CXCL8—atherosclerosis	6.68e-05	0.000602	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—EDN1—atherosclerosis	6.63e-05	0.000598	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—CCL5—atherosclerosis	6.58e-05	0.000593	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—LPL—atherosclerosis	6.43e-05	0.00058	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—PRKCG—atherosclerosis	6.25e-05	0.000564	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—SPP1—atherosclerosis	6.09e-05	0.000549	CbGpPWpGaD
Icatibant—BDKRB2—Signaling by GPCR—CXCL8—atherosclerosis	6.06e-05	0.000547	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—PDGFB—atherosclerosis	5.63e-05	0.000508	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—AGT—atherosclerosis	5.5e-05	0.000496	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—APOE—atherosclerosis	5.39e-05	0.000486	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—LEP—atherosclerosis	5.39e-05	0.000486	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—CAV1—atherosclerosis	5.34e-05	0.000482	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—APOA1—atherosclerosis	5.33e-05	0.000481	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—ESR1—atherosclerosis	5.15e-05	0.000464	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—F2—atherosclerosis	5.08e-05	0.000458	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—PIK3CG—atherosclerosis	4.86e-05	0.000439	CbGpPWpGaD
Icatibant—BDKRB2—Signaling by GPCR—MAPK3—atherosclerosis	4.66e-05	0.00042	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—INS—atherosclerosis	4.6e-05	0.000415	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—CCL2—atherosclerosis	4.53e-05	0.000409	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—IGF1—atherosclerosis	4.45e-05	0.000402	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—SERPINE1—atherosclerosis	4.23e-05	0.000382	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—NOS3—atherosclerosis	4.04e-05	0.000364	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—CXCL8—atherosclerosis	3.58e-05	0.000323	CbGpPWpGaD
Icatibant—BDKRB2—GPCR downstream signaling—AKT1—atherosclerosis	3.46e-05	0.000312	CbGpPWpGaD
Icatibant—BDKRB2—Signaling by GPCR—IL6—atherosclerosis	3.41e-05	0.000307	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—MMP9—atherosclerosis	3.24e-05	0.000292	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—NFKB1—atherosclerosis	3.2e-05	0.000289	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—MAPK8—atherosclerosis	3.15e-05	0.000284	CbGpPWpGaD
Icatibant—BDKRB2—Signaling by GPCR—AKT1—atherosclerosis	3.14e-05	0.000283	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—VEGFA—atherosclerosis	2.91e-05	0.000262	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—STAT3—atherosclerosis	2.88e-05	0.00026	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—MAPK3—atherosclerosis	2.75e-05	0.000248	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—TGFB1—atherosclerosis	2.67e-05	0.000241	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—IL6—atherosclerosis	2.01e-05	0.000181	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—AKT1—atherosclerosis	1.86e-05	0.000167	CbGpPWpGaD
